AstraZeneca (AZNCF) Short Interest Ratio & Short Volume $146.74 +6.11 (+4.34%) As of 05/2/2025 03:46 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartDividendFinancialsHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock AstraZeneca Short Interest DataAstraZeneca (AZNCF) has a short interest of 225,300 shares. This marks a 14.25% increase in short interest from the previous month. The short interest ratio (days to cover) is 53.6, indicating that it would take 53.6 days of the average trading volume of 2,062 shares to cover all short positions.Current Short Interest225,300 sharesPrevious Short Interest197,200 sharesChange Vs. Previous Month+14.25%Dollar Volume Sold Short$30.24 millionShort Interest Ratio53.6 Days to CoverLast Record DateApril 15, 2025Today's Trading Volume1,672 sharesAverage Trading Volume2,062 sharesToday's Volume Vs. Average81% Short Selling AstraZeneca? Sign up to receive the latest short interest report for AstraZeneca and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAZNCF Short Interest Over TimeAZNCF Days to Cover Over TimeAZNCF Percentage of Float Shorted Over Time AstraZeneca Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025225,300 shares $30.24 million +14.3%N/A53.6 $134.22 3/31/2025197,200 shares $29.06 million -38.5%N/A89.6 $147.36 3/15/2025320,500 shares $49.22 million -28.2%N/A100.2 $153.56 2/28/2025446,500 shares $67.18 million +38.4%N/A99.2 $150.46 2/15/2025322,700 shares $47.99 million +23.1%N/A100.8 $148.71 1/31/2025262,200 shares $36.90 million +7.2%N/A46 $140.72 1/15/2025244,700 shares $31.75 million +92.1%N/A41.5 $129.76 12/31/2024127,400 shares $16.56 million +116.7%N/A15 $130.00 12/15/202458,800 shares $7.75 million -69.5%N/A9.3 $131.74 11/30/2024192,900 shares $26.33 million +31.1%N/A40.2 $136.50 Get the Latest News and Ratings for AZNCF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024147,200 shares $18.84 million +248.8%N/A38.7 $127.96 10/31/202442,200 shares $5.99 million +13.8%N/A16.9 $141.90 10/15/202437,100 shares $5.70 million -10.0%N/A17.7 $153.70 9/30/202441,200 shares $6.36 million -2.1%N/A16.5 $154.46 9/15/202442,100 shares $6.66 million +352.7%N/A15 $158.14 8/31/20249,300 shares $1.63 million +1.1%N/A2.7 $175.00 8/15/20249,200 shares $1.54 million -20.7%N/A4.4 $167.00 7/31/202411,600 shares $1.81 million -78.2%N/A2.9 $156.35 7/15/202453,100 shares $8.29 million +140.3%N/A25.3 $156.14 6/30/202422,100 shares $3.45 million +81.2%N/A12.3 $156.27 6/15/202412,200 shares $1.96 million -41.9%N/A3.4 $160.42 5/31/202421,000 shares $3.23 million -74.5%N/A8.8 $153.78 5/15/202482,300 shares $12.59 million -9.2%N/A13.7 $153.00 4/30/202490,600 shares $13.68 million -48.2%N/A5.8 $151.00 4/15/2024174,800 shares $23.76 million +157.8%N/A79.5 $135.94 3/31/202467,800 shares $9.29 million +15.9%N/A20.5 $136.96 3/15/202458,500 shares $7.85 million +24.5%N/A18.9 $134.13 2/29/202447,000 shares $5.95 million +100.9%N/A9.2 $126.63 2/15/202423,400 shares $2.90 million -90.3%N/A1.3 $124.00 1/15/2024232,600 shares $32.51 million +16.9%N/A46.5 $139.76 12/31/2023199,000 shares $26.76 million -44.0%N/A36.3 $134.45 12/15/2023355,200 shares $46.63 million +142.3%N/A65.8 $131.28 11/30/2023146,600 shares $18.84 million +0.2%N/A11.6 $128.50 11/15/2023146,300 shares $18.31 million -7.7%N/A28.1 $125.16 10/31/2023158,500 shares $19.46 million -30.5%N/A35.2 $122.76 10/15/2023228,000 shares $30.89 million +10.7%N/A50.7 $135.50 9/30/2023205,900 shares $27.81 million +95.7%N/A51.5 $135.05 9/15/2023105,200 shares $14.55 million +5.9%N/A15 $138.28 8/31/202399,300 shares $13.31 million +10.7%N/A22.8 $134.04 8/15/202389,700 shares $12.34 million -59.7%N/A24.9 $137.56Virtually Limitless Energy? (Ad)A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.One company’s discovery could change power forever 7/31/2023222,400 shares $32.69 million -51.7%N/A105.9 $147.00 7/15/2023460,100 shares $63.78 million +213.6%N/A184 $138.62 6/30/2023146,700 shares $21.11 million -67.5%N/A66.7 $143.90 6/15/2023451,000 shares $67.31 million +15.1%N/A83.5 $149.25 5/31/2023392,000 shares $57.26 million +314.4%N/A22.5 $146.08 5/15/202394,600 shares $14.14 million -81.2%N/A23.7 $149.45 4/30/2023502,800 shares $73.69 million -9.5%N/A23.4 $146.55 4/15/2023555,700 shares $81.18 million +137.0%N/A86.8 $146.08 3/31/2023234,500 shares $32.87 million +82.8%N/A71.1 $140.16 3/15/2023128,300 shares $16.40 million -71.6%N/A18.9 $127.84 2/28/2023452,200 shares $58.43 million +333.1%N/A145.9 $129.22 2/15/2023104,400 shares $14.70 million -75.7%N/A32.6 $140.78 AZNCF Short Interest - Frequently Asked Questions What is AstraZeneca's current short interest? Short interest is the volume of AstraZeneca shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 225,300 shares of AZNCF short. Learn More on AstraZeneca's current short interest. What is a good short interest ratio for AstraZeneca? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AZNCF shares currently have a short interest ratio of 54.0. Learn More on AstraZeneca's short interest ratio. Is AstraZeneca's short interest increasing or decreasing? AstraZeneca saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 225,300 shares, an increase of 14.2% from the previous total of 197,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short AstraZeneca stock? Short selling AZNCF is an investing strategy that aims to generate trading profit from AstraZeneca as its price is falling. AZNCF shares are trading up $6.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AstraZeneca? A short squeeze for AstraZeneca occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AZNCF, which in turn drives the price of the stock up even further. How often is AstraZeneca's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AZNCF, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies 4Front Ventures Short Squeeze Agentix Short Squeeze Algernon Pharmaceuticals Short Squeeze Alvotech Short Squeeze Anthera Pharmaceuticals Short Squeeze AVVAA World Health Care Products Short Squeeze AXIM Biotechnologies Short Squeeze Bespoke Extracts Short Squeeze BriaCell Therapeutics Short Squeeze Cannabis Global Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:AZNCF) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.